STAT+: Sarepta cleared to test new safety regimen for Duchenne drug

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. We discuss some big news that the Trump administration dropped last night.

And we’ll be taking a break this Thursday and Friday. We’ll see you back on Monday. Happy Thanksgiving!